31P NMR-based plasma profiling reveals metabolic reprogramming in prostate cancer progression
Metabolic reprogramming is a hallmark of prostate cancer progression, and quantitative profiling of metabolites across benign prostatic hyperplasia (BPH), low-, intermediate-, and high-grade tumors provides insights into pathway alterations.
Authors
- V. Kumar
- M. Umar Khan
- R. R. Sorna Kumar
- S. Kaushal
- S.S. Bahukhandi
Institutions
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.iotech.2025.101114
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- International Association for the Study of Lung Cancer
- European Society for Medical Oncology
- Sociedad Española de Oncología Médica